5 completed. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Completed 5 |
Follow Schizophreniform Disorders: new trials by email Literature Review of Schizophreniform Disorders trials Research Report on Schizophreniform Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder Sublingual film containing Igalmi - Bipolar Disorder, Schizophrenia | Phase 4 | Completed | BioXcel Therapeutics Inc | 29 | 2023-10-02 | 2026-08-11 |
| Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis Placebo and fMRI, Lorazepam and fMRI - Schizophrenia, Bipolar Disorder | Phase 4 | Completed | University of Michigan | 143 | 2020-01-16 | 2026-06-17 |
| Research Into Antipsychotic Discontinuation and Reduction Trial Antipsychotic Reduction, Antipsychotic Maintenance - Schizophrenia, Schizoaffective Disorder | Phase 4 | Completed | University College, London | 253 | 2016-03-24 | 2022-05-23 |
| Effects of Pravastatin on Cholesterol, Inflammation and Cognition in Schizophrenia Pravastatin, Placebo - Schizophrenia, Schizoaffective Disorders | Phase 4 | Completed | Massachusetts General Hospital | 60 | 2010-06-01 | 2014-04-28 |
| Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia Ramelteon, Placebo - Schizophrenia, Schizoaffective Disorder | Phase 4 | Completed | Massachusetts General Hospital | 25 | 2008-01-01 | 2012-09-13 |
Psychotic Disorders (5) · Schizophrenia (5) · Bipolar Disorder (2) · Diabetes Mellitus (1) · Inflammation (1) · Psychomotor Agitation (1) · Schizophrenia, Paranoid (1)
Mental Disorders (5) · Schizophrenia Spectrum and Other Psychotic Disorders (5) · Bipolar and Related Disorders (2) · Mood Disorders (2) · Pathological Conditions, Signs and Symptoms (2) · Aberrant Motor Behavior in Dementia (1) · Behavior (1) · Behavioral Symptoms (1) · Dyskinesias (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Metabolic Diseases (1) · Nervous System Diseases (1) · Neurobehavioral Manifestations (1) · Neurologic Manifestations (1)
Dexmedetomidine (1) · Lorazepam (1) · Pravastatin (1) · ramelteon (1)
Massachusetts General Hospital (2) · BioXcel Therapeutics Inc (1) · University College, London (1) · University of Michigan (1)
United States (4) · United Kingdom (1)
BioXcel MM, MD (1) · David C Henderson, M.D. (1) · David C. Henderson, M.D. (1) · Joanna Moncrieff, MBBS (1) · Stephan Taylor, MD (1)
R01MH118634 (1)